Equinatoxin II is a cysteineless pore-forming protein from the sea anemone Actinia equina. It readily creates pores in membranes containing sphingomyelin. Its topology when bound in lipid membranes has been studied using cysteine-scanning mutagenesis. At approximately every tenth residue, a cysteine was introduced. Nineteen single cysteine mutants were produced in Escherichia coli and purified. The accessibility of the thiol groups in lipid-embedded cysteine mutants was studied by reaction with biotin maleimide. Most of the mutants were modified, except those with cysteines at positions 105 and 114. Mutants R144C and S160C were modified only at high concentrations of the probe. Similar results were obtained if membrane-bound biotinylated mutants were tested for avidin binding, but in this case three more mutants gave a negative result: S1C, S13C and K43C. Furthermore, mutants S1C, S13C, K20C, K43C and S95C reacted with biotin only after insertion into the lipid, suggesting that they were involved in major conformational changes occurring upon membrane binding. These results were further confirmed by labeling the mutants with acrylodan, a polarity-sensitive fluorescent probe. When labeled mutants were combined with vesicles, the following mutants exhibited blue-shifts, indicating the transfer of acrylodan into a hydrophobic environment: S13C, K20C, S105C, S114C, R120C, R144C and S160C. The overall results suggest that at least two regions are embedded within the lipid membrane: the N-terminal 13±20 region, probably forming an amphiphilic helix, and the tryptophan-rich 105±120 region. Arg144, Ser160 and residues nearby could be involved in making contacts with lipid headgroups. The association with the membrane appears to be unique and different from that of bacterial pore-forming proteins and therefore equinatoxin II may serve as a model for eukaryotic channel-forming toxins.
Pore-forming peptides and proteins are found in a variety of organisms, such as bacteria, plants, fungi, primitive metazoans, insects and humans [1±5] . They are mostly produced as watersoluble molecules destined to form pores in the lipid membranes of the host organism. Despite their diverse biological roles, most of them function by a common mode of action: they interact with cell or artificial lipid membranes, change conformation and oligomerize in the plane of the membrane to build water-filled pores that are permeable to solutes [6] . Insight into the assembly and operation of such pores calls for their three-dimensional structure. However, at present it is extremely hard to obtain the structure of protein complexes associated with lipids, as is true for membrane proteins [7] . So far, only the structure of a pore created by the bacterial cytolysin, Staphylococcus a-toxin [8] , has been elucidated. In other cases, models of pores have been postulated by applying cysteine-scanning mutagenesis [9±11], fluorescence studies [12, 13] and proteolysis [14] , or have been deduced from the tertiary structure of the monomeric watersoluble form [15±17] .
Equinatoxin II (EqtII), a 179 amino-acid residue cytolysin from Actinia equina [18] , belongs to the family of pore-forming proteins found in sea anemones [2] . Analysis of the amino acid [19±21] and nucleotide [22, 23] sequences showed no similarity to other proteins and they probably represent a novel family. These toxins are characterized by a high pI, a molecular mass of <20 kDa, affinity for sphingomyelin and permeabilizing activity in model lipid and cell membranes [24±26] . The mechanism of EqtII-induced pore formation is a multistep process, involving the monomer binding onto the membrane [27] , insertion and noncovalent oligomerization of monomers into a functional pore with an inner effective hydrodynamic radius of 1.1 nm [25] . Analysis of the dose±response relationship has given a Hill coefficient value of 3±4 [25, 28, 29] for EqtII and sticholysin I. Furthermore, cross-linking on membranes [26] and comprehensive kinetic experiments [30] point to a molecularity of three or four.
As for other eukaryotic pore-forming toxins, molecular details of the mechanism of pore formation by EqtII are not clear. Recent experimental evidence has indicated that EqtII can assume a molten globule state [31, 32] . It is conceivable q FEBS 1999
Topology of membrane-bound equinatoxin (Eur. J. Biochem. 263) 129 that, as in the case of translocating proteins [33] , such a state might allow the toxin to undergo further conformational changes, enabling it to insert into the membrane.
In preliminary studies, we have shown that protein engineering of EqtII in an Eschericia coli expression system [34, 35] is useful to address its structure±function relationship. Here, we took advantage of the fact that EqtII is a cysteineless protein to produce a series of 19 single cysteine mutants. These mutants were used to study the topology of a lipid-bound monomeric form of EqtII, a state which represents an early step in the process leading to the formation of the pore. Mutants have been modified with sulfhydryl-specific reagents, biotin maleimide and fluorescent acrylodan. The overall results suggest that the toxin molecule is anchored to the hydrophobic lipid core by two segments of polypeptide chain, the amphiphilic N-terminal segment and the segment 105±120, and can make additional contacts at the C-terminal region. The majority of the toxin moiety remains located outside the lipid vesicles.
M A T E R I A L S A N D M E T H O D S
Cloning, expression and isolation of cysteine mutants cDNA coding for EqtII (amino-acid sequence below) was amplified by PCR as described previously [22] and mutated using mutagenic oligonucleotides [36] . A series of 19 single cysteine mutants was produced by substituting a wild-type amino-acid residue (underlined) by cysteine as follows :  1  SADVAGAVID  GASLSFDILK  TVLEALGNVK  RKIAVGVDNE SGKTWTALNT 50  51 YFRSGTSDIV LPHKVPHGKA LLYNGQKDRG  PVATGAVGVL AYLMSDGNTL 100  101 AVLFSVPYDY NWYSNWWNVR IYKGKRRADQ  RMYEELYYNL SPFRGDNGWH 150 151 TRNLGYGLKS RGFMNSSGHA ILEIHVSKA 179. Mutations were confirmed by DNA sequencing with a T7 sequencing kit (Pharmacia) and [
S]dATPaS (Amersham).
Products were restricted with appropriate endonucleases, inserted into a pT7-7 vector and expressed in E. coli. Recombinant proteins were purified from the bacterial supernatants as described elsewhere [22] .
Characterization of mutants
Hemolytic activity was measured in a 96-well microtiter plate using a microplate reader (Molecular Devices UV-max) [37] . Toxins were serially diluted twofold in 140 mm NaCl, 10 mm Tris/HCl, pH 7.4 (erythrocyte buffer). A suspension of human red blood cells (HRBC) in erythrocyte buffer with A 650 = 0.1 was added and the time course of hemolysis followed turbidimetrically. Hemolytic activity was expressed as the reciprocal of toxin concentration required for 50% lysis, 1/c 50 . Large unilamellar vesicles (LUVETs), 100 nm in diameter on average, were produced by extrusion [38] using sphingomyelin (AvantiPolar Lipids) and 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (PamOle-GroPCho; Lipoid) at a molar ratio of 3 : 1. Calcein-loaded LUVETs of the same composition were prepared similarly. Permeabilizing activity and the extent of permeabilization of calcein-loaded LUVETs were measured and evaluated as in Belmonte et al. [25] . For binding to LUVETs, toxins at 0.86 mm concentration were incubated with vesicles at a lipid/toxin ratio of at least 400 for 30 min at room temperature. After centrifugation for 90 min at 250 000 g and 4 8C in a Beckman Optima TL centrifuge, which precipitated the vesicles and the bound toxin but not the free toxin (as indicated by controls without vesicles). The hemolytic activity remaining in the supernatant was titrated as above.
Toxin labeling
Mutants were labeled with either biotin maleimide (Sigma) or acrylodan (Molecular Probes). For biotinylation, protein (a few mg) at 2 mm concentration was incubated in 0.05 m Tris/HCl, pH 7.2, with biotin maleimide (probe : toxin molar ratio of 10 : 1) for 30 min at room temperature. Dithiothreitol in excess was added to stop the reaction. For labeling with acrylodan, mutants (50±200 mg) at 5±10 mm concentration were incubated in 0.05 m Tris/HCl, pH 7.1, with dithiothreitol (dithiothreitol : toxin molar ratio of 1 : 1) for 10 min at room temperature and afterwards acrylodan (Molecular Probes; 10 mm in dimethylformamide) was added at a probe : toxin molar ratio of 10 : 1. After 4 h of labeling at room temperature in the dark, the reaction was stopped with excess dithiothreitol. Labeled proteins were separated from unmodified proteins using a hydrophobic interaction chromatography (HIC) column (Brownlee) equilibrated with 0.05 m Tris/HCl, 2 m (NH 4 ) 2 SO 4 , pH 8.3. They were eluted with a linear gradient of (NH 4 ) 2 SO 4 salt decreasing from 100 to 0% in 20 min. Two peaks appeared at 280 nm, one corresponding to the original unmodified mutant, the other to the labeled protein. The extent of protein modification was calculated by the relative areas of these two peaks.
Toxin biotinylation in the presence of LUVETs
Typically, 3 mg of protein were mixed with LUVETs (lipid : toxin molar ratio <400) in 140 mm NaCl, 20 mm Tris/HCl, 1 mm EDTA, pH 7.0 (vesicle buffer), giving a final protein concentration of 0.86 mm in a total of 175 mL. After incubation at room temperature for 30 min, the mixture was centrifuged for 90 min at 250 000 g and 4 8C. The supernatant was removed and the pellet resuspended in 5 mL of the vesicle buffer. To 0.8 mL of vesicle suspension, 1.2 mL of water or biotin maleimide were added to achieve 0, 100, 200, 500 or 1000 mm biotin maleimide. The reaction was stopped after 30 min with excess dithiothreitol. Samples were lyophilized and resuspended in electrophoresis buffer. SDS/PAGE was performed on a PHAST System (Pharmacia) using 10±15% gradient gels. Proteins were transferred to poly(vinylidene difluoride) (PVDF) membranes (Millipore) and stained with an avidin±horseradish peroxidase conjugate using 3-amino-9-ethylcarbazole/H 2 O 2 .
Binding of avidin
To demonstrate the binding of avidin to lipid-bound biotinylated mutants, the following protocol was used. Biotinylated toxin at concentration of 1.7 mm was added to vesicles (lipid/ toxin <400). After 30 min the mixture was centrifuged to pellet vesicles and bound toxin. The supernatant with free toxin was removed and the pellet resuspended in a small volume of vesicle buffer supplemented with avidin. The avidin : toxin molar ratio was <0.5, which corresponded to a biotin-binding sites : toxin ratio of <2 (considering that each avidin molecule has four biotin-binding sites). After incubation for a further 30 min at room temperature, the mixture was separated by SDS/PAGE. Electrophoresed proteins were transferred to PVDF membranes (Millipore) and blotted with rabbit antiEqtII serum for 2 h. Bands were stained with goat anti-rabbit q FEBS 1999 antibodies conjugated with horseradish peroxidase using 3-amino-9-ethylcarbazole/H 2 O 2 .
Fluorescence measurements
The tryptophan fluorescence emission spectra of mutants were measured using a FP-750 fluorimeter (Jasco) at 25 8C. The concentration of mutants was 2.5 mm. The excitation wavelength was 295 nm and emission spectra were recorded from 300 to 400 nm. Excitation and emission slits were set at 10 nm. The fluorescence emission spectra of acrylodan-labeled proteins either alone or combined with LUVETs, were measured using a FluoroMax fluorimeter (Spex) at 25 8C. The concentration of protein was usually 250 nm. LUVETs (PamOleGroPCho/sphingomyelin 1 : 3; diameter 100 nm) were used at a lipid : toxin molar ratio . 400. Spectra were corrected with controls, which were run without protein. The excitation wavelength was 365 nm and emission spectra were recorded from 390 to 600 nm. Excitation and emission slits were set at 2 and 5 nm, respectively.
R E S U L T S Production and characterization of cysteine mutants
Using cDNA for cysteineless EqtII approximately every tenth amino acid was substituted for cysteine. Nineteen single cysteine mutants were produced and purified from bacterial supernatants. The amount of purified proteins was <1 mg´L 21 of culture broth both for wild-type and for all the mutants. These mutants were modified with thiol-specific probes and coupled with vesicles in order to study the location of the modified cysteines. Such an approach is valid only if mutants retain the wild-type conformation and the ability to bind to the membranes and create a functional pore. In order to exclude conformational changes induced by mutations, the tryptophan fluorescence was measured, as it is very sensitive to any change in tryptophan environment [27, 39] . Emission maxima for all mutants are reported in Table 1 . The value of l max for wild-type protein was 335 nm, as already reported [27] , and all mutants were in the range of this value^3 nm. We also used the ratio F 337 /F 350 as an indicator of the folded state of the protein. A value of 1.25 was determined for wild-type in water, but samples denatured either by guanidinium or urea had a value of 0.78, which indicates that all tryptophans are fully exposed to water [27] . All mutants had values very close to that of the wild-type protein in water, indicating the absence of any major conformational change. Furthermore, their biological activity was determined by measuring the hemolysis of HRBC or permeabilization of lipid vesicles. All mutants were hemolytically active, although five of them showed , 20% wild-type activity ( Table 1 ). The greatest reduction factor was <150-fold for S54C. LUVETs permeabilizing activity correlated well with hemolysis, with just a few differences: K20C, K43C and S167C were relatively more active on vesicles than on HRBC, whereas the opposite was true for S105C and E134C. All mutants, despite the observed differences in biological activity, retained the ability to bind to LUVETs to approximately the same extent, as judged by SDS/PAGE (not shown) and from the titration of the hemolytic activity remaining in solution after the vesicles with the bound fraction are precipitated by centrifugation ( Table 1 ). The possibility that mutants with low activity bound to the membranes only superficially, without inserting into the lipid core, seems unlikely. In fact, as we will show in the following, many such mutants (e.g. R31C, S54C, K77C and S167C) retain all the Table 1 . Properties of cysteine mutants. The tryptophan fluorescence emission spectra of mutants, each at a 2.5-mm concentration, were measured at 25 8C. Hemolytic activity was measured in a 96-well microtiter plate. It is expressed as the reciprocal of toxin concentration required for 50% lysis. The mean of triplicate experiments is reported, relative variation was within^15%. The extent of permeabilization at a toxin concentration of 0.25 mm was evaluated using calcein-loaded LUVETs, composed of PamOle-GroPCho/sphingomyelin 1 : 3. Representative results are shown. Binding to LUVETs was estimated from the hemolytic activity of unbound toxin. The average of three to eight repetitions is shown, relative variation was within^25%. ND, not determined. regions involved in lipid binding completely intact. Therefore, the strongly reduced permeabilizing activity of these mutants and S114C should rather be sought in the deficiency of a step after binding, either a further conformational change of the toxin or its oligomerization into a functional pore.
Labeling of toxins in solution
No reaction between the sulfhydryl-specific probes and wildtype EqtII was detected, but most of the EqtII single cysteine mutants did react. Selective labeling with biotin maleimide was proved by SDS/PAGE and hydrophobic chromatography. Cysteines could be reacted after 15 min incubation at a probe : mutant molar ratio of 100 : 1 or after 30 min at a 10-fold lower ratio (Fig. 1) . The yield of labeling, as obtained from the HPLC profile, was mutant dependent and ranged from , 1% for K43C to 100% for H67C (Table 2) . Mutant toxins were also reacted with acrylodan. The extent of acrylodan labeling correlated well with biotin labeling (Table 2) apart from a few exceptions which will be discussed later. According to the labeling results, two groups of mutants may be clearly identified: those with cysteine at positions 54, 67, 77, 126, 152 and 179, which were readily labeled with both probes, and those with cysteine at positions 1, 120, 144 and 160, which did not react appreciably with any label. The major factor determining the range of reactivity is steric accessibility. Therefore, the first group represents residues that are exposed on the surface of the protein, whereas cysteines in the second group are conceivably buried or shielded from the solvent. In the case of Ser at position 1, for example, this is consistent with independent evidence that it is not possible to oxidize this residue in native EqtII using the Dixon method [40] and that the N-terminal residues are not cleaved by aminopeptidase M (unpublished result). In between these two extremes, we found mutants which were efficiently labeled with at least one label. For example, mutants S13C, K20C, R31C, K43C, S95C, S105C and S114C were labeled to a large extent with acrylodan, but not with biotin maleimide. This suggests the presence of a hydrophobic surface close to these residues which is more accessible to acrylodan than to biotin maleimide because of the stronger hydrophobicity of the former. Indeed, Ser95, Ser105 and Ser114 are, according to a hydropathy plot, located in the most hydrophobic region of the protein [21] . In contrast, E134C and S167C were readily labeled with biotin maleimide, but not with acrylodan. A hydrophilic environment around these residues probably prevents its association with hydrophobic acrylodan. After labeling and separation, labeled mutants retained their hemolytic activity.
Labeling of toxins bound to LUVETs
During the binding of the toxin to the membranes conformational changes are expected to occur [21] , so we tested the reactivity of the cysteine mutants in the membrane-bound form. For this, mutants were first bound to the vesicles, then separated from the unbound, and finally reacted with biotin maleimide. Labeled proteins were detected on the blots by staining them either with anti-EqtII serum or with avidin±horseradish peroxidase (Fig. 2) . All cysteine mutants bound to the LUVETs. Since biotin maleimide, at the low concentrations used (i.e. 100 mm), is a membrane impermeant reagent [41, 42] the labeling of mutants indicated their exposure to the solvent. The possibility that biotinylation occurs on the trans side via diffusion through the open pores is very unlikely, since we have chosen conditions (i.e. lipid/toxin ratio <400) such that the number of pores is virtually nil [30] . As summarized in Table 2 , 10 of 14 mutants tested were readily modified with 100 mm biotin maleimide. Mutants S13C and A179C are two such examples (Fig. 2) . Mutants R144C and S160C were modified only at 1 mm concentration of the probe, indicating a reduced accessibility of the sulfhydryl group to the probe. Mutants S105C and S114C were not biotinylated at all indicating that these two residues were not accessible either in solution or bound to the vesicles. Interestingly, mutants S1C, S13C, K20C, K43C and S95C were modified with 100 mm of biotin maleimide on the vesicles, whereas they were poorly labeled in free solution at the same probe concentration (Table 2 ). This suggests that conformational changes occur around these positions on binding to membrane and expose this part of the molecule to biotin maleimide.
Binding of avidin to membrane-bound biotinylated toxins
In a complementary approach we determined the accessibility of avidin to the biotin on labeled, vesicle-bound, mutants. In this case, mutants biotinylated in solution, were bound to the LUVETs, separated from unbound and finally incubated with avidin. The binding of avidin was indicated by the appearance of an 80-kDa band on SDS/PAGE which was composed specifically of mutant protein (<20 kDa) and avidin (<60 kDa), as it could be stained with either anti-EqtII serum or biotinylated horseradish peroxidase (Fig. 3) . Examples of mutants that bound avidin (A179C, K20C and S95C) and mutants that did not (S105C and S160C) are reported in Fig. 3 (lanes 3, 5±6 and 7±9, respectively). Wild-type toxin treated with biotin maleimide or nonbiotinylated mutants, did not bind avidin (lanes 1 and 2). As summarized in Table 2 , 11 of 18 mutants tested were able to bind avidin. Because all mutants were able to bind to the vesicles (see lower bands representing monomer in Fig. 3 ), the absence of the 80 kDa band could be due to one of the following reasons: the biotinyl moiety was not accessible, because it was located in the lipid phase, or at the interface between monomers or at the inner face of the vesicles; the yield of biotinylation was too low to detect as a band. Indeed, although all mutants were biotinylated, the yield was not the same for all of them (Table 2) . However, the sensitivity of the method was such that even at very low yields of biotinylation, some mutants could readily be shown to bind avidin (e.g. K20C and S95C). Therefore, the low yield of 3 . SDS/PAGE analysis of avidin binding to membrane-bound biotinylated EqtII mutants. Mutant toxins were biotinylated, bound to the vesicles and, after coupling with avidin, subjected to SDS/PAGE. After blotting they were stained with anti-EqtII serum, except the sample in lane 4, which was stained with biotinylated peroxidase. The band at 20 kDa is monomeric EqtII, whereas the band at 40 kDa represents a dimer which is present also in the wild-type and is not due to disulfide bond formation as it is resistant to dithiothreitol. The 80 kDa band composed of biotinylated mutant and avidin is denoted by an arrow. Complexes of avidin and more than one mutant may also be seen in lane 3. Lane 1, wild-type EqtII treated with biotin; lane 2, nonbiotinylated A179C; lanes 3±8, biotinylated mutants A179C, A179C, K20C, S95C, S105C and S160C, respectively.
biotinylation was probably not the reason for the absence of the band. Interestingly, S1C, S13C and K43C, although biotinylated when bound to the membranes, were not able to bind avidin (Table 2 ). This could be due to steric hindrance which prevents the association of the larger avidin molecule with the biotinyl group in the N-terminal region, but allows biotinylation with smaller reagent to occur at the same position [43] . The alternative explanation that biotinylation occurs at the trans side is not likely because of the experimental conditions chosen, as explained above. In any case, this possibility would be limited to positions 1 and 13, since position 43 is located between two residues which are accessible to avidin (i.e. 31 and 54) and therefore, it is also most probably located on the cis side.
Acrylodan as a probe of toxin±membrane interaction
In studies of protein±membrane interactions, acrylodan labeling of a protein has been used to monitor local polarity changes of a particular residue [10, 11] . We scanned the fluorescence emission spectra of acrylodan-labeled EqtII cysteine mutants in free solution and when bound to LUVETs. In some cases a blue-shift was observed indicating transfer of acrylodan to a less polar environment (Fig. 4) . This effect was markedly dependent on the lipid/toxin ratio, reaching a plateau when most of the toxin was bound at a lipid/toxin ratio . 400 (see R144C in Fig. 4A ). Therefore, a lipid/toxin ratio . 400 was used throughout. Two typical examples are presented in Fig. 4B . Mutant H67C did not show any shift after addition of liposomes, whereas mutant S160C showed a blue-shift of <60 nm. The observed emission maxima of all acrylodanlabeled mutants, either in solution or coupled with vesicles, are shown in Fig. 5 . Maxima around 520 nm were found for all labeled mutants in solution, indicating exposure of the label to the water phase. This was expected, since acrylodan labeling occurs on thiol groups located on or near the surface of the protein.
The blue-shift after interaction with lipids was observed for positions 13 and 20 of the N-terminal region, positions 105, 114 and 120 at the mid-part of the molecule and positions 144 and 160 proximal to the C-terminus. Positions 134 and 167 were only poorly labeled (Table 2) and accordingly these data are missing in Fig. 5 . The quantum yield of acrylodan fluorescence after binding to the vesicles was slightly greater for those mutants that exhibited the blue-shift, which is consistent with its transfer to a less polar environment [44] .
D I S C U S S I O N
We have addressed the question of determining which parts of EqII are involved in membrane binding. We decided to perform cysteine-scanning mutagenesis, by substituting approximately every tenth residue in the wild-type molecule with a cysteine. We performed three kinds of experiments: we checked the accessibility of newly introduced cysteines in the membranebound form of the toxin to two reagents, a small one, biotin maleimide, and a larger one, avidin. In addition, using acrylodan labelling, we monitored the interaction of specific regions of the mutants with the lipid bilayer. The results are fluorescence spectra of H67C and S160C, before (solid line) and after combining with LUVETs (dotted line) are shown as examples, at a lipid/ toxin ratio of 450 for H67C and 560 for S160C. Excitation wavelength was 365 nm, emission spectra were recorded from 390 to 600 nm. q FEBS 1999 summarized in Table 2 and a model of membrane-bound EqtII is presented in Fig. 6 . According to these, the residues at the following positions were unaffected in their accesibility to solvent by binding the toxin to the membrane: 67, 95, 126, 134, 152 and 179. Mutants bearing a cysteine at these positions were fully active, some even more than the wild-type. In addition, it was possible to label them when bound to the vesicles either with biotin maleimide or with avidin, when they were previously biotinylated, and finally they did not exhibit any acrylodan emission shift. Our results lead to the conclusion that areas around these residues are not involved in any interaction whatsoever, either with the lipid bilayer or with other monomers in assembled pores. We consistently obtained the same result with contiguous residues at positions 31, 54, 77 and 167 (Fig. 6) . However, the results with these last mutants cannot be interpreted on their own because their hemolytic activity was much reduced. All other mutants tested showed reduced accessibility to biotin maleimide, could not bind avidin, or exhibited a large blue-shift in acrylodan emission, when bound to the membrane (Table 2 ). In principle, at least two steps in the formation of an EqtII pore could be responsible for the above results: initial binding of monomers to the membranes and subsequent oligomerization into a functional pore. However, it has been shown that the most abundant form of the toxin on the membrane is the monomer and that the fraction of toxin associated in pores is actually small [25, 30] . Furthermore, EqtII oligomeric structures on the membrane are not stable, as are some other pore-forming proteins [45±47], and their existence could only be demonstrated indirectly by cross-linking experiments and kinetic measurements [25, 30] . At the typical lipid/toxin value of 400, chosen for our experiments, we observed that <80% of the protein is bound (Table 1) . This implies an average partition coefficient of 2 Â 10 4 m 21 , which compares nicely with values previously observed for other actinoporins, which ranged from 1 Â 10 4 to 2 Â 10 4 m 21 [30, 48] and is similar, for example, to that of melittin which is 4 Â 10 4 m 21 [49] . Consequently, between 100 and 200 monomers are bound per vesicle, depending on the mutant. On the other hand, we know from permeabilization experiments that the number of pores present is never more than 2±3 per vesicle at a lipid/toxin ratio of 10, and certainly smaller at a lipid/toxin ratio of 400. This clearly indicates that most of the toxin is not in the oligomeric form. If we increase the lipid/toxin ratio further, then the amount of bound toxin increases, but the extent of pore formation decreases, as there is less toxin available on a single vesicle to form a pore [27, 30] . Therefore, the increased effects observed at a lipid/toxin ratio of 1900 for example (Fig. 4) lead to the conclusion that acrylodan changes are the consequence of interaction of the toxin with the membrane and not of pore formation. Taken together, these considerations show that our experiments relate to the monomeric bound toxin, although some limited association between monomers bound to the membrane may also take place. Accordingly, three regions of EqtII can be envisaged to interact with the lipid phase: the N-terminal part, the central hydrophobic region 105±120 and the C-terminal part around mutations R144C and S160C (Fig. 6) .
The N-terminal part of EqtII contains a predicted amphiphilic a-helix at position 11±33 [21] which, according to Eisenberg et al. [50] , is a surface-seeking helix and therefore should lay flat on the membrane surface with hydrophilic residues Ser13, Asp17, Lys20, Glu24 and Asn28, facing the polar solvent. Our results are consistent with this picture since mutants S13C and K20C were labeled with biotin maleimide, a membrane impermeant molecule and biotinylated K20C was also accessible to avidin. The accompanying slight blue-shift of acrylodan is compatible with their transfer to a lipid/water interface environment. It is conceivable that the hydrophobicity of the acrylodan moiety might induce a small rotation of the helix enabling the probe to partition into the interface. The alternative explanation that the a-helix is spanning the lipid membrane and positions 13 and 20 are located at the interface is not likely. In fact, the distance between residues 13 and 20, in a-helical conformation, is too long to accommodate both probes in the interfacial space on one side of the membrane and Fig. 6 . Putative topology of a membrane bound EqtII monomer. Based on our results and data from other studies [27, 34, 55] a model of the topology of membrane-bound EqtII monomer is presented. Circled residues are those that were mutated, with the number indicating the position where a single cysteine was introduced. The positions of the five tryptophan residues of EqtII are also indicated with smaller circles. White residues are those for which all the topological experiments indicated that they remain exposed to the solution after interaction with the membrane. Lightly shaded residues are also exposed to the outside but they did not bind avidin. Black residues are those which interact with the lipids. Double circled residues are those that, while being fully consistent with the proposed model, should be considered with some caution having a reduced hemolytic activity. Lipid-interacting residues 13 and 20 were apparently inserted less deeply into the membrane than the others, since the acrylodan shift was smaller and they were able to bind biotin at normal concentrations. Residues 144 and 160 were also biotinylated in the membrane-bound form, but only at a 10 times higher biotin concentration. Circles shaded from the outside are for those residues where a conformational change is indicated by the fact that they become accessible to biotin modification only after interaction with the membrane. According to these results at least two regions of EqtII clearly interact with the lipid membrane: the tryptophan-rich region 105±120, deeply inserted into the lipid core, which could span the membrane in an extended conformation, and the amphiphilic N-terminal helix (residues 13±31) probably remaining flat on the membrane surface. Our data also imply that there are no long loops exposed to the trans side. too short to have one residue on the cis and the other on the trans side. N-terminal truncation mutagenesis of EqtII revealed that the N-terminus itself is not essential for binding of toxin to the lipids, in fact deletion mutants showed enhanced binding, but is important for membrane permeabilization [34] . Once bound, it may stabilize the toxin on the surface of the lipid membrane and assist the insertion of other parts of the protein in the lipid phase. Interestingly, a major conformational change in this region of the toxin, occurring when it binds to the lipid, is indicated by the fact that residues at positions 1, 13, 20 and 43 are biotinylated in the lipid-bound form, but not in the soluble one. This would support the conclusion that the amphiphilic helix is folded differently in the water-soluble state, protecting these residues from labeling.
The emission blue-shift of acrylodan-labeled mutants S105C and R120C indicates partitioning of this central region into the lipid phase. Mutant S105C was also inaccessible to any of the probes, once bound to the vesicles. Mutant S114C behaved exactly as S105C, although less weight may be laid on this result in view of the fact that this mutant retained only 11% of the wild-type hemolytic activity. The remarkable hydrophobicity of the region 80±117 of EqtII (as seen in a hydropathy plot; [21] ), indeed makes it a strong candidate for insertion into the hydrophobic phase. It would be long enough to adopt a helical hairpin, spanning the lipid bilayer, as reported for colicin A, for example [51] . However, accessibility of avidin to lipid-bound biotinylated S95C shows that this residue is extravesicular and thus makes this possibility unrealistic. One alternative explanation could be that this hydrophobic region forms one or two b-stranded hairpins inserted into the lipid bilayer, thus leaving Ser95 exposed. In this way, joining three or four monomers, the walls of a pore with radius of < 1 nm (a dimension reported for both EqtII and sticholysin; [25, 30] ) could be created. As for the N-terminus helix, the occurrence of a conformational change in this region on binding to the lipid is indicated by the fact that Ser95 can be biotinylated on the vesicles, but not in solution.
The region 112-WYSNWW-117 contains three tryptophans that may lie on the cis surface of the vesicle membrane, because biotinylated R126C was found to be accessible to avidin and because the transfer of the stretch 123-KGKRR-127 across the lipid bilayer to the intravesicular side of the membrane would be energetically highly unfavorable. This region resembles the aromatic cluster WEWW found in the bacterial pore-forming toxin perfringolysin O whose importance for binding to lipid membranes and for toxin activity was demonstrated by sitedirected mutagenesis [52] . Furthermore, the crystal structures of two pore-forming toxins (aerolysin and staphylococcal atoxin; [8, 15] ) and of the invertebrate K + channel [53] show that they all have many solvent-exposed tyrosine and tryptophan residues located near the lipid membrane surface in the assembled pore. Using model peptides, it has been shown that tryptophan, phenylalanine and tyrosine contribute substantially to the free energy of peptide partitioning to the lipid±water interface [54] . Therefore, it is reasonable to propose that residues 105±120 and tryptophans in that region have a similar position and function in the assembled EqtII pore.
An acrylodan blue-shift was also observed in the region 144±160. This part is considerably more hydrophilic than both the N-terminal and the 105±120 regions [21] , and its insertion into a lipid core would not be expected. However, it is possible that this portion is involved in the interaction with polar head groups and that the shift of acrylodan fluorescence occurs because the label, due to its hydrophobicity, is transferred to the acyl chains of the lipids. The role of the C-terminal part for the action of the toxin should be investigated more in detail.
In conclusion, we present evidence that, in the early stages of pore formation EqtII is bound to the lipid membrane by at least two separate regions: the tryptophan-rich region 105±120 and the N-terminus 11±30. The N-terminus partitions into the lipid±water interface and stabilizes the monomeric molecule on the membrane. Binding is accompanied by conformational rearrangements in both those regions of the toxin.
